Press release
Animal Model Market is anticipated to grow at a CAGR of 6.1% till 2030 | Taconic Biosciences, Janvier Labs, LLC, Crown Bioscience Inc., Charles River Laboratories, Trans Genic
The global animal model market was valued at $1,469 million in 2020, and is projected to reach $2,677 million by 2030, registering a CAGR of 6.1% from 2021 to 2030.๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐ญ๐ก๐ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.alliedmarketresearch.com/request-sample/6464
Market Drivers:
Research and Development in Pharmaceuticals and Biotechnology: The pharmaceutical and biotechnology industries heavily rely on animal models for preclinical research in drug discovery and development. Animal models are essential for evaluating drug safety, efficacy, and toxicity before advancing to human clinical trials. The ongoing research and development activities in these sectors drive the demand for animal models.
Rising Incidence of Diseases: The increasing prevalence of diseases, such as cancer, cardiovascular disorders, neurodegenerative diseases, and infectious diseases, fuels the demand for animal models. Animal models provide a valuable tool for studying disease mechanisms, identifying potential drug targets, and developing new therapies. They help researchers understand disease progression and test the effectiveness of novel treatment approaches.
Market Segmentation:
By Type of Animal Model:
a. Rodents (Mice, Rats): Rodents are the most commonly used animal models in research due to their genetic similarity to humans, ease of handling, and cost-effectiveness.
b. Rabbits: Rabbits are used in various research areas, including ophthalmology, cardiovascular research, and vaccine development.
c. Dogs and Cats: These animal models are primarily used in veterinary research and certain specific human diseases.
d. Non-Human Primates: Non-human primates, such as monkeys, are used for complex research involving diseases that closely resemble human conditions.
By Research Application:
a. Drug Discovery and Development: Animal models are extensively used in preclinical research to evaluate the safety, efficacy, and pharmacokinetics of potential drug candidates.
b. Disease Research: Animal models are used to study various diseases, including cancer, cardiovascular diseases, neurodegenerative disorders, and infectious diseases.
c. Genetic Research: Animal models with specific genetic modifications are used to study gene function, genetic diseases, and potential therapeutic interventions.
d. Toxicology Testing: Animal models are used to assess the toxicity and potential adverse effects of chemicals, drugs, and environmental factors.
By End User:
a. Pharmaceutical and Biotechnology Companies: These companies utilize animal models extensively for drug discovery, preclinical testing, and regulatory compliance.
b. Academic and Research Institutions: Academic institutions and research organizations use animal models for a wide range of studies, including basic research, disease modeling, and drug development.
c. Contract Research Organizations (CROs): CROs specialize in providing animal models and related services to support research activities of pharmaceutical and biotechnology companies.
By Geography:
The animal model market can be segmented based on geographical regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Regional variations may exist in terms of research activities, regulatory frameworks, and market demand.
These are general segmentation approaches, and the actual segmentation may vary based on specific market studies and industry perspectives.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ญ๐ข๐จ๐ง:
https://www.alliedmarketresearch.com/request-for-customization/8311
Competitive Landscape:
Charles River Laboratories International, Inc.
The Jackson Laboratory
Envigo
Taconic Biosciences, Inc.
JANVIER LABS
genOway S.A.
Trans Genic Inc.
Horizon Discovery Group plc
Crown Bioscience, Inc.
Harlan Laboratories, Inc.
Procure Complete Report at 20% Discount (258 Pages):
https://www.alliedmarketresearch.com/purchase-enquiry/8311
๐๐จ๐ซ๐ญ๐ก ๐๐ฆ๐๐ซ๐ข๐๐ ๐ ๐๐ซ๐ง๐๐ซ๐๐ ๐ญ๐ก๐ ๐ฆ๐๐ฃ๐จ๐ซ ๐ฌ๐ก๐๐ซ๐ ๐ข๐ง ๐๐๐๐-
By region, North America held the major share in 2020, garnering nearly two-fifths of the global animal model market, owing to increase in preclinical activities by pharmaceutical and biotech companies during drug development, rise in use of animal models by CROs, and surge in focus on personalized medicines in this region. The market across Asia-Pacific, on the other hand, would cite the fastest CAGR of 7.3% during the forecast period, due to increase in research on biomedical and regenerative medicines, rise in awareness related to animal models, and availability of trained medical professionals in this province.
Related Reports :
Exosome Diagnostic and Therapeutic Market: https://www.alliedmarketresearch.com/exosome-diagnostic-and-therapeutic-market
Bone Grafts and Substitutes Market: https://www.alliedmarketresearch.com/bone-graft-substitutes-market
Negative Pressure Wound Therapy Devices Market: https://www.alliedmarketresearch.com/negative-pressure-wound-therapy-market
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Animal Model Market is anticipated to grow at a CAGR of 6.1% till 2030 | Taconic Biosciences, Janvier Labs, LLC, Crown Bioscience Inc., Charles River Laboratories, Trans Genic here
News-ID: 3336616 • Views: โฆ
More Releases from Allied Market Research
IoT Sensors Market to Garner $141.80 Billion, Globally, By 2030 at 28.1% CAGR: A โฆ
Allied Market Research recently published a report, titled, "IoT Sensors Market By Type (Temperature Sensor, Proximity Sensor, Pressure Sensor, Level Sensor, Gas Sensor, Image Sensor, Optical Sensor, Gyroscope Sensor, Humidity Sensor, Accelerometer Sensor, and Others), Network Technology (Wired and Wireless) and End Use (Consumer Electronics, Automotive, Industrial Healthcare, Food & Beverages, Aerospace & Defense, Transportation, Agriculture, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030". As per the report, theโฆ
5G Infrastructure Market to Reach $83.62 Billion, Globally, By 2030 at 45.3% CAG โฆ
Allied Market Research published a report, titled, "5G Infrastructure Market By Communication Infrastructure (Small Cell, Macro Cell, Radio Access Network, and Distributed Antenna System), Network Technology (Software Defined Networking, Network Chipset Type Virtualization, Mobile Edge Computing, and Fog Computing), Chipset Type (Application Specific Integrated Circuit, Radio Frequency Integrated Circuit, mmWave Integrated Circuit, and Field Programmable Gate Array), Application (Automotive & Transportation, Energy & Utilities, Healthcare, Retail, Consumer Electronics, Industrial Automation,โฆ
Digital Remittance Market to Reach $102.2 billion, Globally, by 2033 at 17.4% CA โฆ
Allied Market Research published a report, titled, "Digital Remittance Market by Fee Type (Inward and Outward), Channel (Banks, Money Transfer Operators, and Others), and End User (Business and Personal): Global Opportunity Analysis and Industry Forecast, 2024-2033". According to the report, the "digital remittance market" was valued at $20.2 billion in 2023, and is estimated to reach $102.2 billion by 2033, growing at a CAGR of 17.4% from 2024 to 2033.โฆ
Remote Deposit Capture Market to Reach $558.0 Million, Globally, by 2032 at 6.2% โฆ
Allied Market Research published a report, titled, "Remote Deposit Capture Market by Component (Solution and Service), by Deployment Mode (On-Premise and Cloud), and Enterprise Size (Small and Medium-sized Enterprises and Large Enterprises): Global Opportunity Analysis and Industry Forecast, 2024-2032". According to the report, the remote deposit capture market was valued at $324.8 million in 2023, and is estimated to reach $558.0 million by 2032, growing at a CAGR of 6.2%โฆ
More Releases for Animal
Animal Health Market Sets the Table for Continued Growth : Zoetis Animal Healthc โฆ
Advance Market Analytics published a new research publication on "Animal Health Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Animal Health market was mainly driven by the increasing R&D spending across the world. Some of the key players profiledโฆ
Animal Antimicrobials and Antibiotics Market 2023 Growth and Development By Bion โฆ
Antibiotics, also called antibacterials, are a type of antimicrobial drug used in the treatment and prevention of bacterial infections. They may either kill or inhibit the growth of bacteria. Animal Antimicrobials and Antibiotics includes Premixes, Oral Powders, Oral Solutions and Injections on the base of classification, which represent 12.4%, 14.4%, 10.4% and 56.6% of global Animal Antimicrobials and Antibiotics market.
Get Sample Copy: https://www.worldwidemarketreports.com/sample/273708
Farm Animals and Companion Animals are theโฆ
Animal Healthcare Market Analysis Focusing on Top Key Players - Merck, Bayer Ani โฆ
Worldwide Market Reports recently released on the Animal Healthcare market for the forecast period, 2017 โ 2022 is involved in screening the business environment and the companies operating in the Animal Healthcare industry. Importantly, the research sheds a lot of light on their winning strategies to help stakeholders, business owners, and field marketing executives stay ahead in the competition. Besides, the industry is thoroughly weighed upon on the basis ofโฆ
Animal Model Market trends, Animal Model Market growth, Animal Model Market size โฆ
Key Findings of Animal Model Market
Developing Regions to Overpower Developed Ones With Regard to Demand
The Asian territory is on the verge of evolving as the next big destination for animal models. This growth can be attributed to various factors such as American and European pharmaceutical companies diversifying their research activities to curtail extra expenses and save costs. Although U.S and Europe have retained their legacy in the global market, theirโฆ
Animal Growth Promoter Market Outlook To 2023 โ Bayer Animal Health, Biomin, B โฆ
Nov 2018, New York USA (News)- Different categories of feed additives for farm animals are referred to as natural growth promoters (NGPs) or non-antibiotic growth promoters. They are commonly regarded as favorable alternatives to antibiotic growth promoters (AGPs) in livestock production. NGPs include predominantly organic acids, probiotics, prebiotics, synbiotics, phytogenics, tannins, feed enzymes and immune stimulants, an ongoing search for alternatives has created a large variety of NGPs for pigs,โฆ
Animal Antimicrobials and Antibiotics Market Key Players : Animal Health, Bayer โฆ
The term antibiotic or antimicrobial is used for those agents who kill or inhibit the growth of microorganism. The antimicrobials products have significant benefits to the animal and to human food safety. There are researches, which have proven that an increase in the rate of animal illness results in higher rate of human illness. Therefore, livestock dealers depend on animal antibiotics to provide safe food. The scope of this reportโฆ
